Natalizumab Efficacy of 4- to 6-Week Dosing Schedule Switch in Multiple Sclerosis
Researchers assessed the efficacy of a natalizumab 6-week dosing schedule in patients with multiple sclerosis who received natalizumab 4-week dosing without relapse for 12 or more months.